Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis ...

The 48-year-old Pekin native and PGA veteran returned to host the 2025 Renewal by Anderson D.A. Points Junior Open, an American Junior Golf Association tour event created with his backing to help ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...